Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

Viral Infections, Non-HIV

Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case-control matched multicenter study (BACTCOVID)

Clin Microbiol Infect

Abelenda-Alonso G, Rombauts A, Gudiol C, Oriol I, Simonetti A, Coloma A, Rodríguez-Molinero A, Izquierdo E, Díaz-Brito V, Sanmartí M, Padullés A, Grau I, Ras MM, Bergas A, Guillem L, Blanco-Arévalo A, Alvarez-Pouso C, Pallarés N, Videla S, Tebé C, Carratalà J

doi: 10.1016/j.cmi.2021.06.041

Viral Infections, Non-HIV

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study

Eur J Intern Med.

Campochiaro C, Della-Torre E, Cavalli G, De Luca G, Ripa M, Boffini N, Tomelleri A, Baldissera E, Rovere-Querini P, Ruggeri A, Monti G, De Cobelli F, Zangrillo A, Tresoldi M, Castagna A, Dagna L, TOCI-RAF Study Group.

doi: 10.1016/j.ejim.2020.05.021.

Viral Infections, Non-HIV

Clinical Characteristics and Predictors of Disease Progression in Severe Patients with COVID-19 Infection in Jiangsu Province, China: A Descriptive Study

Am J Med Sci.

Huang M, Yang Y, Shang F, Zheng Y, Zhao W, Luo L, Han X, Lin A, Zhao H, Gu Q, Shi Y, Li J, Xu X, Liu K, Deng Y, Cao Q, Wang W

doi: 10.1016/j.amjms.2020.05.038.

Viral Infections, Non-HIV

Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicenter study

Clin Microbiol Infect.

Bartoletti M, Marconi L, Scudeller L, Pancaldi L, Tedeschi S, Giannella M, Rinaldi M, Bussini L, Valentini I, Ferravante AF, Potalivo A, Marchionni E, Fornaro G, Pascale R, Pasquini Z, Puoti M, Merli M, Barchiesi F, Volpato F, Rubin A, Saracino A, Tonetti T, Gaibani P, Ranieri VM, Viale P, Cristini F, PREDICO study group.

doi: 10.1016/j.cmi.2020.09.014.

Viral Infections, Non-HIV

Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China

Clin Microbiol Infect.

Zhang J, Wang X, Jia X, Li J, Hu K, Chen G, Wei J, Gong Z, Zhou C, Yu H, Yu M, Lei H, Cheng F, Zhang B, Xu Y, Wang G, Dong W

doi: 10.1016/j.cmi.2020.04.012.

Viral Infections, Non-HIV

Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-Cov-2 infection: a multicenter cohort study (PREDI-CO study)

Clin Microbiol Infect.

Bartoletti M, Giannella M, Scudeller L, Tedeschi S, Rinaldi M, Bussini L, Fornaro G, Pascale R, Pancaldi L, Pasquini Z, Trapani F, Badia L, Campoli C, Tadolini M, Attard L, Puoti M, Merli M, Mussini C, Menozzi M, Meschiari M, Codeluppi M, Barchiesi F, Cristini F, Saracino A, Licci A, Rapuano S, Tonetti T, Gaibani P, Ranieri VM, Viale P, PREDICO study group.

doi: 10.1016/j.cmi.2020.08.003.

Viral Infections, Non-HIV

Outcomes in Patients with Severe COVID-19 Disease Treated with Tocilizumab - A Case- Controlled Study

QJM.

Rojas-Marte GR, Khalid M, Mukhtar O, Hashmi AT, Waheed MA, Ehrlich S, Aslam A, Siddiqui S, Agarwal C, Malyshev Y, Henriquez-Felipe C, Sharma D, Sharma S, Chukwuka N, Rodriguez DC, Alliu S, Le J, Shani J

doi: 10.1093/qjmed/hcaa206.

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

Lancet Infect Dis.

Gutiérrez-Gutiérrez B, Salamanca E, de Cueto M, Hsueh PR, Viale P, Paño-Pardo JR, Venditti M, Tumbarello M, Daikos G, Cantón R, Doi Y, Tuon FF, Karaiskos I, Pérez-Nadales E, Schwaber MJ, Azap ÖK, Souli M, Roilides E, Pournaras S, Akova M, Pérez F, Bermejo J, Oliver A, Almela M, Lowman W, Almirante B, Bonomo RA, Carmeli Y, Paterson DL, Pascual A, Rodríguez-Baño J; REIPI/ESGBIS/INCREMENT Investigators

doi: 10.1016/S1473-

Viral Infections, Non-HIV

Combined use of the neutrophil-to-lymphocyte ratio and CRP to predict 7-day disease severity in 84 hospitalized patients with COVID-19 pneumonia: a retrospective cohort study

Ann Transl Med.

Liu YP, Li GM, He J, Liu Y, Li M, Zhang R, Li YL, Wu YZ, Diao B

doi: 10.21037/atm-20-2372.

Related content

Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case-control matched multicenter study (BACTCOVID)

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study

Clinical Characteristics and Predictors of Disease Progression in Severe Patients with COVID-19 Infection in Jiangsu Province, China: A Descriptive Study

Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicenter study

Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China

Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-Cov-2 infection: a multicenter cohort study (PREDI-CO study)

Outcomes in Patients with Severe COVID-19 Disease Treated with Tocilizumab - A Case- Controlled Study

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

Combined use of the neutrophil-to-lymphocyte ratio and CRP to predict 7-day disease severity in 84 hospitalized patients with COVID-19 pneumonia: a retrospective cohort study